NCBiotech News

A business unit of Wilmington-based global contract research organization PPD is launching a five-year study involving 30,000 people throughout the U.S. age 50 and older, to explore ways to prevent and treat dementia.

Durham-based Tergus Pharma expects to add 200 workers over the next five years after it converts a newly acquired 100,000-square-foot building into a new headquarters and commercial manufacturing facility. 

Worldwide Clinical Trials, a Morrisville clinical research organization with operations in 60 countries, is meeting fast-changing needs in oncology and rare disease clinical trials.

Newly spawned IQVIA MedTech says it will leverage several practice areas from its growing Research Triangle operations.

Hydromer Inc., a company producing polymers for use in medical, industrial and “green chemistry” applications, is moving its headquarters and manufacturing from New Jersey to North Carolina.

Burlington-based LabCorp has launched a new diagnostic test that brings precision medicine to certain cancer patients.

Lindy Biosciences, a biotech company developing innovative drug formulation technology that was bootstrapped by a loan from the North Carolina Biotechnology Center, has now completed a $1.6M Series A round.

EG-GILERO, a Morrisville-based medical device manufacturer, plans to invest more than $4 million and create 60 jobs in Chatham County, adding more finished-device assembly to augment its design, development and manufacturing services.

FHI 360, a Durham-based international nonprofit human development organization, has launched a subsidiary called FHI Clinical as a full-service contract research organization to manage complex clinical research in resource-limited settings around the world.

CiVentiChem, a pharmaceutical contract development and manufacturing company with international headquarters in Cary, has been purchased by Sterling Pharma Solutions, a British company in the same business.

Lenoir is a small town in the rural foothills, away from the state’s renowned technology hubs. But it's home to Exela Pharma Sciences, a fast-growing manufacturer of generic sterile injectable medications backed by venture capital, government grants and loans, investments by family and friends and personal funds of founder Phanesh Koneru. In its first decade it has grown to 320 employees, and it’s hiring more.

To add momentum to the fast-growing field of precision medicine, Durham-based IQVIA has launched a patented new technology platform for life science customers to access big data needed for a wide range of research activities.

A north Raleigh drug-manufacturing site purchased in 2014 by Denmark-based Xellia Pharmaceuticals has been sold again -- this time to Sagent Pharmaceuticals of Schaumburg, Illinois.

Durham-based TARGET PharmaSolutions, a clinical data company focused on real-world evidence in disease studies, has launched a new observational study of several inflammatory skin conditions, initially focusing on eczema.

IQVIA, established two years ago following the 2016 merger of Research Triangle-based Quintiles and IMS Health, has announced the launch of IQVIA Biotech. This new unit will design clinical and commercial solutions for small biotechnology and biopharmaceutical companies.